Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept

Abstract

The Observe-and-Plan regimen significantly improved VA, while fewer monitoring visits were needed as compared to other variable dosing regimens, thus reducing the workload for chronic care management of nAMD.